Search results
Idiopathic sudden sensorineural hearing loss (ISSNHL) is common, and defined as a sudden decrease in sensorineural hearing sensitivity of unknown aetiology. Systemic corticosteroids are widely used, however their value remains unclear.
Objective: To determine the evidence for efficacy of intratympanic (IT) steroid treatment for the management of idiopathic sudden sensorineural hearing loss through a systematic review of the existing literature.
Idiopathic sudden sensorineural hearing loss (ISSHL) is the sudden loss of unilateral hearing of unknown etiology. The standard treatment consist of a high dose oral steroid taper. This article serves to review the current literature on intratympanic steroid injections for ISSHL.
4 lip 2023 · Intratympanic steroid injection is used to treat cochleovestibular symptoms of inner ear disease, such as Meniere's disease or idiopathic sudden sensorineural hearing loss. This procedure involves using a syringe needle to penetrate the tympanic membrane to inject the steroid into the middle ear.
Idiopathic sudden sensorineural hearing loss (ISSNHL) constitutes up to 90% of cases and is defined by acute hearing loss developed within 72 hours with a decrease in hearing of at least 30 dB at 3 consecutive frequencies on pure-tone audiometry. 2 Idiopathic sudden sensorineural hearing loss is almost exclusively unilateral and typically ...
Objective: Administration of steroids systematically is considered to be the most commonly accepted treatment for idiopathic sudden sensorineural hearing loss (ISSNHL). In recent years there has been increasing scientific interest in treating ISSNHL by means of local steroid delivery.
1 mar 2024 · Intratympanic steroids (ITS) in treating sudden sensorineural hearing loss (SSNHL) have become more widespread. Aim. This study investigates whether ITS treatment provides additional benefits when combined with systemic steroids (SS) in patients with severe and profound SSNHL. Materials and methods.
